Sign Out
Each film-coated tablet contains 59.12 mg, 44.34 mg, or 29.56 mg.
2-butenamide, N-[4-[3(-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2E)-, (2Z)-2-butenedioate (1:2) (= afatinib dimaleate) (corresponding to afatinib base form 40 mg, 30 mg, or 20 mg).
Afatinib film-coated tablets, 20 mg are white to slightly yellowish, round, biconvex, bevel-edged tablets. One side is debossed with the code T20, the other side is debossed with the Boehringer Ingelheim company symbol.
Afatinib film-coated tablets, 30 mg are dark blue, round, biconvex, bevel-edged tablets. One side is debossed with the code T30, the other side is debossed with the Boehringer Ingelheim company symbol.
Afatinib film-coated tablets, 40 mg are light blue, round, biconvex, bevel-edged tablets. One side is debossed with the code T40, the other side is debossed with the Boehringer Ingelheim company symbol.
Excipients/Inactive Ingredients: Tablet Core: lactose monohydrate, microcrystalline cellulose (E460), colloidal anhydrous silica (E551), crospovidone, magnesium stearate (E470b).
Film coating: hypromellose 2910 (E464), macrogol 400, titanium dioxide (E171), talc (E553b), polysorbate 80 (E433), Colourant containing indigo carmine (E132) aluminium hydroxide (only used for 40 mg and 30 mg tablets).
Continue with Google